T4(Levothyroxine) 400 MCG

Levothyroxine Sodium (commonly known by brand names such as Synthroid, Eltroxin, or Euthyrox) is a synthetic form of Thyroxine (T4), the primary pro-hormone naturally secreted by the thyroid gland. In the body, T4 acts as a precursor that is converted into the biologically active thyroid hormone, Triiodothyronine (T3), via peripheral deiodinase enzymes ($D1$ and $D2$).

Because T4 must undergo enzymatic conversion to T3, its action is smoother, more stable, and more self-limiting than direct T3 administration. In clinical settings, Levothyroxine is the primary standard-of-care replacement therapy for hypothyroidism. In research, performance, and metabolic protocols, T4 provides a sustained baseline elevation of thyroid hormone activity, supporting basal metabolic rate and enhancing lipolysis while mimicking natural thyroid output. A 400mcg formulation represents an extremely high, maximum-potency dose typically reserved for severe clinical deficiencies, myxedema management, or split micro-dosing protocols.

Key Benefits & Applications

• Self-Regulating Metabolic Baseline: Because peripheral tissues convert T4 into T3 on an as-needed basis via deiodinase enzymes, T4 provides a more steady, controlled metabolic baseline with fewer sharp spikes in heart rate or body temperature compared to direct T3 administration.

• Stable Blood Plasma Concentrations: With its long 7-day half-life, daily administration builds a very stable plasma concentration, preventing energy crashes and dramatic hormonal fluctuations.

• Synergy with Growth Hormone (hGH): Recombinant human growth hormone therapy accelerates the conversion of T4 to T3 in the liver. Administering T4 during hGH protocols prevents T4 depletion and optimizes GH-induced lipolysis and tissue growth.

• Enhanced Lipid Oxidation & BMR: Increases systemic oxygen consumption, heat production (thermogenesis), and baseline lipid and carbohydrate turnover.

• Sustained Fat Loss: Helps offset the natural drop in thyroid output caused by prolonged caloric restriction during extended dieting phases.